Abstract:Background Ferroptosis is an emerging iron-dependent programmed cell death mode characterized by lipid peroxidation and iron accumulation, closely associated with Hepatocellular Carcinoma (HCC) progression. Although the impact of Polyphyllin I (PPI), a prominent bioactive constituent derived from Paris polyphylla , on diverse malignancies has been established, the specific role and potential mechanistic pathways through which PPI modulates ferroptosis in HCC remain elusive. Purpose This study aimed to elucidate the anti-cancer properties and potential mechanisms of PPI in inducing ferroptosis and triggering mitochondrial injury in HCC. Methods Cell viability was assessed using CCK-8 assays. EdU proliferation and colony formation assays were employed to evaluate cell proliferation. A wound-healing assay was performed to assess cell migration. Transwell assay was utilized to evaluate cell invasion. Ferroptosis was evaluated through the utilization of a FerroOrange fluorescent probe, malondialdehyde (MDA) and reduced glutathione (GSH) assay kits, DCFH-DA fluorescent probe, western blotting, and Transmission electron microscopy (TEM) analysis. Molecular docking, Immunofluorescence, and western blotting were employed to predict and validate the binding and interaction of PPI with Nrf2, HO-1, xCT, and GPX4. Mitochondrial structure and membrane potential changes were evaluated using JC-1 and Mito Tracker Green fluorescent probes. A nude mice xenograft model was constructed to determine the inhibitory effects and the levels of ferroptosis of PPI on HCC through Hematoxylin and eosin (H&E), Prussian blue reaction, immunofluorescence staining, immunohistochemistry, and western blotting analysis, in vivo . Results PPI exhibited dose-dependent inhibitory effects on the proliferation, invasion, and metastasis of HCC cells mediated by increasing reactive oxygen species (ROS) and MDA levels, promoting Fe 2+ accumulation, depleting GSH, and suppressing the expression of xCT and GPX4, thereby inducing ferroptosis in HCC. The induction of ferroptosis by PPI was associated with the binding of PPI to Nrf2, HO-1, and GPX4 proteins, modulating the Nrf2/HO-1/GPX4 antioxidant axis. PPI also induced mitochondrial structural damage and decreased mitochondrial membrane potential (MMP). Inhibition of ferroptosis by ferrostatin-1 (Fer-1) mitigated the mitochondrial disruption induced by PPI. In vivo , PPI inhibited Nrf2/HO-1/GPX4 axis-induced ferroptosis, impeding HCC growth similar to the effects of sorafenib. Conclusion These results demonstrated that PPI intervention can suppress the proliferation, invasion, and metastasis of HCC cells by enhancing mitochondrial disruption and inducing ferroptosis via the Nrf2/HO-1/GPX4 axis. Consequently, our research advances the frontiers of pharmacodynamics and deepens our comprehension of the intricate mechanisms underpinning PPI. Furthermore, it has yielded an innovative treatment stratagem rooted in the tenets of Traditional Chinese Medicine (TCM), thereby furnishing a novel therapeutic avenue for addressing HCC.

The Insulin-Like Growth Factor-I Receptor Inhibitor Picropodophyllin-Induced Selective Apoptosis Of Hepatocellular Carcinoma Cell Through A Caspase-Dependent Mitochondrial Pathway

Inhibition of Type I Insulin-Like Growth Factor Receptor Tyrosine Kinase by Picropodophyllin Induces Apoptosis and Cell Cycle Arrest in T Lymphoblastic Leukemia/Lymphoma

The Association of Tp53 Mutations with the Resistance of Colorectal Carcinoma to the Insulin-Like Growth Factor-1 Receptor Inhibitor Picropodophyllin

Abnormal Expression of Insulin-Like Growth Factor-I Receptor in Hepatoma Tissue and Its Inhibition to Promote Apoptosis of Tumor Cells

Role of the Death Receptor and Endoplasmic Reticulum Stress Signaling Pathways in Polyphyllin I-Regulated Apoptosis of Human Hepatocellular Carcinoma HepG2 Cells

Picropodophyllin Inhibits Type I Endometrial Cancer Cell Proliferation Via Disruption of the PI3K/Akt Pathway.

Therapeutic Inhibition of Phospholipase D1 Suppresses Hepatocellular Carcinoma.

IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms−

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway

Polyphyllin I induced ferroptosis to suppress the progression of Hepatocellular Carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis

Downregulation of Peptidylprolyl Isomerase A Promotes Cell Death and Enhances Doxorubicin-Induced Apoptosis in Hepatocellular Carcinoma.

Novel 2-Phenyloxypyrimidine Derivative Induces Apoptosis and Autophagy Via Inhibiting PI3K Pathway and Activating MAPK/ERK Signaling in Hepatocellular Carcinoma Cells.

Dual Role of PID1 in Regulating Apoptosis Induced by Distinct Anticancer-Agents Through AKT/Raf-1-dependent Pathway in Hepatocellular Carcinoma

IGF-1R Down Regulates the Sensitivity of Hepatocellular Carcinoma to Sorafenib Through the PI3K / Akt and RAS / Raf / ERK Signaling Pathways

PP-10 Induces Apoptosis Via JNK/SPAK Activation and STAT3 Inhibition in Hepatocarcinoma Cells in Vitro

Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells

Ponicidin Promotes Hepatocellular Carcinoma Mitochondrial Apoptosis by Stabilizing Keap1‐PGAM5 Complex

Picropodophyllin Inhibits the Growth of Ewing's Sarcoma Cells Through the Insulin-Like Growth Factor-1 Receptor/akt Signaling Pathway

Hepatopoietin Cn Suppresses Apoptosis of Human Hepatocellular Carcinoma Cells by Up-Regulating Myeloid Cell Leukemia-1.

Phellinus igniarius polysaccharides induced mitochondrial apoptosis of hepatic carcinoma by enhancing reactive oxygen species-mediated AKT/p53 signalling pathways